null

Tocilizumab (Anti-IL6R) Biosimilar Antibody

SKU:
HDBS0041
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
IL-6R
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-IL6R tocilizumab biosimilar mAb HDBS0041
  • Anti-IL6R tocilizumab biosimilar mAb HDBS0041
  • Anti-IL6R tocilizumab biosimilar mAb HDBS0041
$448
Frequently bought together:

Description

system_update_altDatasheet

Tocilizumab (Anti-IL6R) Biosimilar Antibody (HDBS0041)

The Anti-IL6R (Tocilizumab) Biosimilar MAb (HDBS0041) is a monoclonal antibody designed for research involving Interleukin-6 Receptor (IL6R), a cell surface protein involved in immune responses and inflammation regulation. This biosimilar monoclonal antibody, similar to Tocilizumab, is highly reactive with human samples and is validated for use in various research applications, including ELISA and immunohistochemistry.IL6R is a critical receptor in the IL-6 signaling pathway, which plays a key role in regulating inflammation, immune responses, and acute phase reactions.

Targeting IL6R with monoclonal antibodies like Tocilizumab has shown promise in treating conditions such as rheumatoid arthritis, cytokine release syndrome, and other inflammatory disorders. The Anti-IL6R (Tocilizumab) Biosimilar MAb (HDBS0041) provides researchers with a valuable tool for studying the IL6R pathway and developing new therapies for inflammatory diseases.